Systemic mastocytosis (Q39209): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
A mastocitose sistêmica (MS) compreende um grupo heterogêneo de neoplasias malignas hematológicas adquiridas e crônicas raras que estão relacionadas a uma proliferação anormal de mastócitos no tecido, incluindo medula óssea, com ou sem envolvimento da pele. MS pode ser dividido em MS indolente (MSI) e MS agressiva (MSA). | |||
| description / en | description / en | ||
Systemic mastocytosis (SM) comprises a heterogeneous group of rare acquired and chronic haematological malignancies that are related to an abnormal proliferation of mast cells in tissue, including bone marrow, with or without skin involvement. SM can be divided into indolent SM (ISM) and aggressive SM (ASM). | |||
Revision as of 04:32, 13 August 2026
Systemic mastocytosis (SM) comprises a heterogeneous group of rare acquired and chronic haematological malignancies that are related to an abnormal proliferation of mast cells in tissue, including bone marrow, with or without skin involvement. SM can be divided into indolent SM (ISM) and aggressive SM (ASM).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 2A21.0 |
||
| English | Systemic mastocytosis |
Systemic mastocytosis (SM) comprises a heterogeneous group of rare acquired and chronic haematological malignancies that are related to an abnormal proliferation of mast cells in tissue, including bone marrow, with or without skin involvement. SM can be divided into indolent SM (ISM) and aggressive SM (ASM). |
